Simplicity Wealth’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Simplicity Wealth's BIIB Position: Q1 2026 in Review
Simplicity Wealth increased its Biogen (BIIB) stake by 10% in Q1 2026, buying an estimated $36.3K and bringing the position to 2,149 shares worth $394K. The position accounts for 0.02% of the portfolio, ranked #519.
Simplicity Wealth first reported a position in BIIB in Q1 2024 and has held it in 6 quarters since. The position peaked at $445K in Q1 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Simplicity Wealth held 2,149 shares of Biogen worth $394K as of Q1 2026.
- Simplicity Wealth bought 197 Biogen shares in Q1 2026, an estimated $36.3K.
- Biogen made up 0.02% of Simplicity Wealth's portfolio in Q1 2026, its #519 holding.
- Simplicity Wealth first reported a position in Biogen in Q1 2024 and has held it in 6 quarters since.
- Simplicity Wealth's Biogen position peaked at $445K in Q1 2024.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Simplicity Wealth's 13F filing for Q1 2026, filed 30 Apr 2026.